Stocktoria
SB Technology Holdings, Inc. VGLS
OTC · stock · Pharmaceutical Preparations · website · IPO 1999-12-07
SB Technology Holdings, Inc. financials (annual, from 10-K)
Bars are annual figures from 2013 to 2014; red bars are negative (a loss or cash outflow).
| Metric | FY2014 | FY2014 | FY2013 |
|---|---|---|---|
| Revenue | $0 | $347,750 | $0 |
| R&D expense | $865,702 | $19.0M | $808,517 |
| Operating income | -$4.1M | -$65.3M | -$3.9M |
| Interest expense | $2.8M | $36.3M | $1.1M |
| Income tax | $0 | — | $0 |
| Net income | -$6.2M | -$105.5M | -$7.4M |
| Operating cash flow | -$1.9M | -$22.9M | -$1.0M |
| Free cash flow | -$1.9M | -$23.3M | -$1.0M |
| Total assets | $1.3M | $1.1M | $1.9M |
| Shareholders' equity | -$4.5M | -$5.2M | -$4.5M |
Growth · year-over-year
| Metric | FY2014 | FY2014 | FY2013 |
|---|---|---|---|
| Revenue growth | -100.0% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001091326 · US · as of 2014-12-31. facts plus Stocktoria's own computed scores — not investment advice.